share_log

港股午评 | 三大指数集体下跌,部分医美概念股逆市上扬,时代天使涨超4%

Afternoon comment on Hong Kong stocks | the three major indexes fell collectively, while some medical and beauty stocks rose against the market, while Angelalign Technology Inc. rose more than 4%.

富途資訊 ·  Jul 27, 2022 12:19

Futu Information July 27 | the three major indexes of Hong Kong stocks fluctuated lower, the Hang Seng Index closed down 1.51% at midday, and the Hang Seng Technology Index fell 1.65%.

By midday's close, Hong Kong stocks were up 384, down 1173, and closed flat at 1337.

big

The specific industry performance is shown below:

big

Plate aspectScience and Internet stocks generally fell.BABA fell nearly 4%, XIAOMI fell more than 2%, Tencent fell 2%, Meituan and JD.com fell more than 1%.

Some medical and beauty stocks rose.Angelalign Technology Inc. rose by more than 4%, Haohai Biotechnology by more than 1%, Sihuan Pharmaceutical and Kangzhe Pharmaceutical by nearly 1%.

Weakening of the inner housing and property management sectorCountry Garden Holdings fell nearly 14%, Xuhui holding Group fell by more than 11%, Country Garden Services Holdings fell by nearly 19%, Xuhui Yongsheng Service fell by more than 10%, and Sunac Services fell by more than 8%.

Auto stocks fell.Li Auto Inc. fell by more than 4%, NIO Inc. and Geely Automobile by more than 3%, XPeng Inc. and Great Wall Motor by more than 2%, and Byd Company Limited by nearly 2%.

General decline in anti-epidemic concept stocksShandong Xinhua Pharmaceutical fell by more than 7%, the development pharmaceutical industry fell by nearly 5%, CANSINOBIO fell by nearly 4%, Ping An Healthcare And Technology and clover fell by more than 2%.

Pharmaceutical outsourcing concept stocks weaken collectivelyWeiya Bio and Wuxi Apptec fell nearly 5%, Wuxi Biologics fell more than 4%, and Kailiying and Tigermed fell more than 2%.

Individual stocks$Beijing Oriental Jingdian (00710.HK) $Increase by more than 5%The stock price has doubled in the past two months and recently entered into a main framework agreement with BOE.

$Gao Wei Electronics (01415.HK) $Increase by more than 7%The share price has doubled in the past month.

$China Shipping Defense (00317.HK) $Pull up nearly 10%The market capitalization is back above HK $10 billion.

$Tengshengbo Medicine-B (02137.HK) $Increase by more than 8%It was previously announced that COVID-19 's combination therapy remained neutralizing to Omicron.

$MINISO Group (09896.HK) $Drop by more than 10%MINISO Group responded to the Blue Orca Capital short selling report that the report was groundless and contained misleading conclusions and interpretations about the company's information.

$Huijing Holdings (09968.HK) $Up nearly 67%Trading resumed today, after falling more than 88 per cent before trading was suspended on July 22nd, when Huijing Holdings announced that 315 million shares held by controlling shareholders had been forcibly sold.

HSBC Research: up-regulation$Xiexin Technology (03800.HK) $Target price to HK $5, ratingBuy

HSBC Research released a report that recently visited Xiexin Technology's new factory in Leshan, Sichuan, and reacted positively to the new factory after discussion with investors. The bank expects that the new plant in Baotou will start production in November this year, which will provide the company with an additional 100000 tons of industrial silicon production. In addition to the existing channel capacity, the company plans to open other production plants to achieve an annual output of 20 to 300000 tons. The bank said that in view of the increased demand for solar energy in overseas markets, the company was looking to open factories overseas and was considering co-investing in its factories with downstream customers in the future. The bank raised the group's 2022-23 profit forecast by 25% to 28%, higher than the market forecast of 10% to 69%, and raised its target price from HK $4.7 to HK $5, maintaining its "buy" rating.

Half-day turnover TOP20

logo

Edit / irisz

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment